Billionaire Prem Watsa’s Top 15 Long-Term Stock Picks

Page 7 of 15

9. Pfizer Inc. (NYSE:PFE)

Number of Hedge Fund Holders: 80 

Fairfax Financial Holdings’ Stake: $13.3 million  

Pfizer Inc. (NYSE:PFE) discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The following points illustrate the company’s robust investment outlook. Firstly, as per the report for the third quarter of 2024, performance was driven by focused commercial execution and robust double-digit revenue growth across the product portfolio. Additionally, the company raised full-year 2024 revenue guidance to a range of $61 to $64 Billion and raised adjusted diluted EPS guidance to a range of $2.75 to $2.95. This demonstrates the strong business growth of the company and its confidence in its future performance. Secondly, the company has selected its preferred once-daily modified-release formulation for danuglipron, an oral glucagon-like peptide-1 (GLP-1) receptor agonist. Pfizer plans to conduct dose optimization studies, evaluating multiple doses of the preferred modified release formulation to inform the registration enabling studies.

Page 7 of 15